Both physical inactivity and disruptions in the gut microbiome appear to be prevalent in
patients with chronic kidney disease (CKD). Engaging in physical activity could present a …

Chronic kidney disease (CKD) patients have several metabolic disorders caused by chronic
oxidative stress and inflammation. The imbalance of gut microbiota has been identified as a …

Protein-energy wasting (PEW) is common in patients with chronic kidney disease (CKD) and
is associated with increased morbidity and mortality, and lower quality of life. It is a complex …

There is increasing interest in the therapeutic potential of manipulating the gut microbiome
of patients with chronic kidney disease (CKD). This is because there is a substantial …

Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …

There is increasing clinical evidence that patients with chronic kidney disease (CKD) have a
distinctly dysbiotic intestinal bacterial community, termed the gut microbiota, which in turn …

Survival outcomes of patients with end stage renal disease are worse than those of many
metastatic cancers. Kidney disease patients are often inflicted with higher rates of …

The gut microbiota consists of trillions of microorganisms, fulfilling important roles in
metabolism, nutritional intake, physiology and maturation of the immune system, but also …

Recent advances in microbiome research have informed the potential role of the gut
microbiota in the regulation of metabolic, cardiovascular, and renal systems, and, when …

RECENT OMICS-BASED STUDIES have helped elucidate the influence of gut microbiota on
human health and disease. The diverse community of microorganisms that inhabit the …